Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $14.61 USD
Change Today +0.51 / 3.62%
Volume 40.1K
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

invuity inc (IVTY) Snapshot

Open
$13.91
Previous Close
$14.10
Day High
$14.79
Day Low
$13.85
52 Week High
06/16/15 - $15.59
52 Week Low
08/12/15 - $10.00
Market Cap
194.4M
Average Volume 10 Days
30.3K
EPS TTM
--
Shares Outstanding
13.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INVUITY INC (IVTY)

Related News

No related news articles were found.

invuity inc (IVTY) Related Businessweek News

No Related Businessweek News Found

invuity inc (IVTY) Details

Invuity, Inc., a medical technology company, various surgical devices to address various surgical procedures in the United States. The company integrates its intelligent photonics technology platform into its single-use and reusable advanced surgical devices to address various critical intracavity illumination and visualization challenges. It offers various illuminated surgical devices, including Eikon illuminated retractor systems for breast oncology/oncoplastic/general/orthopedics surgeries; Eika illuminated retractor systems for anterior neck approaches comprising thyroid and cervical spine surgeries; Breiten illuminated retractor systems for spine surgeries; Eipex illuminated retractor systems for spine/orthopedic surgeries; Eivector illuminated retractor systems for orthopedic surgeries; Saber Yankauer, a handheld illuminator for orthopedic/spine/cardiothoracic/breast/general surgeries; Saber Frazier, a handheld illuminator for spine/orthopedic/neurosurgery surgeries; and Waveguide XT system, a drop-in intracavity illuminator for spine surgeries. The company sells its devices through its direct sales representatives and original equipment manufacturers of surgical systems; and directly to hospitals and surgeons. The company was formerly known as Spotlight Surgical, Inc. and changed its name to Invuity, Inc. in 2007. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California.

121 Employees
Last Reported Date: 08/12/15
Founded in 2004

invuity inc (IVTY) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $375.0K
Vice President of Operations
Total Annual Compensation: $70.9K
Vice President of Research and Development
Total Annual Compensation: $24.6K
Compensation as of Fiscal Year 2014.

invuity inc (IVTY) Key Developments

Invuity, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Invuity, Inc. reported unaudited earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported revenue of $4,747,000 against $2,816,000 a year ago. Loss from operations was $8,866,000 against $5,113,000 a year ago. Net loss was $9,346,000 against $5,456,000 a year ago. Net loss per common share, basic and diluted was $3.20 against $8.40 a year ago. For the six months, the company reported revenue of $9,189,000 against $4,970,000 a year ago. Loss from operations was $16,979,000 against $9,483,000 a year ago. Net loss was $18,378,000 against $10,168,000 a year ago. Net loss per common share, basic and diluted was $10.11 against $15.75 a year ago.

Invuity, Inc. Names James H. Mackaness as Chief Financial Officer, with Effective from August 24, 2015

Invuity, Inc. announced the appointment of medical device financial and operations executive James H. Mackaness as its chief financial officer, effective August 24th. Mackaness will report directly to President and CEO Philip Sawyer. Mackaness brings more than 20 years of experience as a senior financial executive to the company, having worked for both public and private companies in the Bay Area. His wide-ranging expertise includes financial and strategic planning, public reporting and controls, mergers and acquisitions, and operations management within the medical device and technology industries. Most recently, Mackaness served as chief financial officer and chief operating officer for IRIDEX Corp. Prior to IRIDEX, Mackaness was the CFO at two privately-held companies one of which was sold to Cisco Systems where he went on to assume a business development role. Early in his career, he was an audit manager for Ernst & Young LLP.

Invuity, Inc. to Report Q2, 2015 Results on Aug 11, 2015

Invuity, Inc. announced that they will report Q2, 2015 results After-Market on Aug 11, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IVTY:US $14.61 USD +0.51

IVTY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Stryker Corp $99.69 USD -1.39
View Industry Companies
 

Industry Analysis

IVTY

Industry Average

Valuation IVTY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.5x
Price/Book 3.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 6.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INVUITY INC, please visit www.invuity.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.